BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 23909507)

  • 21. The Outcomes of Pituitary Apoplexy with Conservative Treatment: Experiences at a Single Institution.
    Seo Y; Kim YH; Dho YS; Kim JH; Kim JW; Park CK; Kim DG
    World Neurosurg; 2018 Jul; 115():e703-e710. PubMed ID: 29709755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Socioeconomic factors associated with pituitary apoplexy.
    Jahangiri A; Clark AJ; Han SJ; Kunwar S; Blevins LS; Aghi MK
    J Neurosurg; 2013 Dec; 119(6):1432-6. PubMed ID: 23889139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pituitary tumor apoplexy: characteristics, treatment, and outcomes.
    Verrees M; Arafah BM; Selman WR
    Neurosurg Focus; 2004 Apr; 16(4):E6. PubMed ID: 15191335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spontaneous regression of non-functioning pituitary adenoma due to pituitary apoplexy following anticoagulation treatment - a case report and review of the literature.
    Zieliński G; Witek P; Koziarski A; Podgórski J
    Endokrynol Pol; 2013; 64(1):54-8. PubMed ID: 23450448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ischemic pituitary adenoma apoplexy-Clinical appearance and prognosis after surgical intervention.
    Ogawa Y; Niizuma K; Mugikura S; Tominaga T
    Clin Neurol Neurosurg; 2016 Sep; 148():142-6. PubMed ID: 27449534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Manifestation, management and outcome of subclinical pituitary adenoma apoplexy.
    Zhang F; Chen J; Lu Y; Ding X
    J Clin Neurosci; 2009 Oct; 16(10):1273-5. PubMed ID: 19577475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid resolution of a third nerve palsy from pituitary apoplexy.
    Hanna V; Mednick Z; Micieli J
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33958366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pituitary Apoplexy: Results of Surgical and Conservative Management Clinical Series and Review of the Literature.
    Almeida JP; Sanchez MM; Karekezi C; Warsi N; Fernández-Gajardo R; Panwar J; Mansouri A; Suppiah S; Nassiri F; Nejad R; Kucharczyk W; Ridout R; Joaquim AF; Gentili F; Zadeh G
    World Neurosurg; 2019 Oct; 130():e988-e999. PubMed ID: 31302273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK).
    Fernandez A; Karavitaki N; Wass JA
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):377-82. PubMed ID: 19650784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary tumor apoplexy.
    Johnston PC; Hamrahian AH; Weil RJ; Kennedy L
    J Clin Neurosci; 2015 Jun; 22(6):939-44. PubMed ID: 25800143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review.
    Raj R; Elshimy G; Jacob A; Arya PVA; Unnikrishnan DC; Correa R; Myint ZW
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2337-2347. PubMed ID: 34156518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome.
    Möller-Goede DL; Brändle M; Landau K; Bernays RL; Schmid C
    Eur J Endocrinol; 2011 Jan; 164(1):37-43. PubMed ID: 20926593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complex effects of apoplexy secondary to pituitary adenoma.
    Zhang RC; Mu YF; Dong J; Lin XQ; Geng DQ
    Rev Neurosci; 2017 Jan; 28(1):59-64. PubMed ID: 27802176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conservative management of pituitary tumor apoplexy.
    Santos AB; França MM; Hirosawa RM; Marivo M; Zanini MA; Nunes VS
    Arq Bras Endocrinol Metabol; 2011 Jun; 55(5):345-8. PubMed ID: 21881818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical intervention for pituitary apoplexy: an analysis of functional outcomes.
    Rutkowski MJ; Kunwar S; Blevins L; Aghi MK
    J Neurosurg; 2018 Aug; 129(2):417-424. PubMed ID: 28946177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of pituitary apoplexy.
    Deb S
    J Indian Med Assoc; 1998 Oct; 96(10):302-3, 307. PubMed ID: 10063297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pituitary apoplexy in giant cell adenoma].
    Ulitin AIu; Oliushin VE; Mel'kishev VF
    Vopr Onkol; 2007; 53(3):339-44. PubMed ID: 18198618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome in pituitary apoplexy patients, stratified by delay between symptom appearance and surgery: A single center retrospective analysis.
    Cabuk B; Kaya NS; Polat C; Geyik AM; Icli D; Anik I; Ceylan S
    Clin Neurol Neurosurg; 2021 Nov; 210():106991. PubMed ID: 34700278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sudden headache, third nerve palsy and visual deficit: thinking outside the subarachnoid haemorrhage box.
    Ní Chróinín D; Lambert J
    Age Ageing; 2013 Nov; 42(6):810-2. PubMed ID: 23913476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative Neurologic Outcome in Patients with Pituitary Apoplexy After Transsphenoidal Surgery.
    Kim YH; Cho YH; Hong SH; Kim JH; Kim MS; Khang SK; Lee EJ; Chong K; Kim CJ
    World Neurosurg; 2018 Mar; 111():e18-e23. PubMed ID: 29191540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.